Cerebello-striatal interaction mediates effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
10 2019
Historique:
received: 18 01 2019
revised: 30 08 2019
accepted: 02 09 2019
pubmed: 9 9 2019
medline: 25 8 2020
entrez: 9 9 2019
Statut: ppublish

Résumé

In Parkinson's disease (PD), dopamine replacement therapy (DRT) enhances the effective connectivity of the prefrontal cortex (PFC) and supplementary motor area (SMA). The clinical effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) go beyond DRT effects including highly beneficial tremor suppression. Here, we aimed to determine DBS-related changes of a motor network using resting state fMRI in PD patients with chronic STN DBS. In a repeated-measurement design, 26 medicated PD patients (60.9 years (SD 8.9)) were investigated using resting state fMRI while bipolar STN stimulation was (i) active or (ii) switched off, and dynamic causal modelling was subsequently performed. DBS improved the MDS-UPDRS-III score by 26.4% (DBS ON/Med ON vs. DBS OFF/Med ON). Active stimulation resulted in an increased effective connectivity from cerebellum to putamen (p = 0.00118). In addition, there was a stronger coupling from PFC to cerebellum (p = 0.021), as well as from cerebellum to SMA (p = 0.043) on an uncorrected level. Coupling strength from PFC to cerebellum correlated with the DBS-related change of the resting tremor subscore (r = 0.54, p = 0.031). Self-connections increased as a function of DBS in the right PFC, PMC, SMA, M1, thalamus and left cerebellum. DBS-related improvement of Parkinsonian signs appears to be driven by an interaction between the cerebellum and the putamen. Resting tremor suppression may be related to an enhanced prefronto-cerebellar network. Activation of the mesial premotor loop (PFC-SMA) as seen in DRT may thus be secondary due to the primary modulation of cerebellar networks.

Sections du résumé

BACKGROUND
In Parkinson's disease (PD), dopamine replacement therapy (DRT) enhances the effective connectivity of the prefrontal cortex (PFC) and supplementary motor area (SMA). The clinical effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) go beyond DRT effects including highly beneficial tremor suppression.
OBJECTIVES
Here, we aimed to determine DBS-related changes of a motor network using resting state fMRI in PD patients with chronic STN DBS.
METHODS
In a repeated-measurement design, 26 medicated PD patients (60.9 years (SD 8.9)) were investigated using resting state fMRI while bipolar STN stimulation was (i) active or (ii) switched off, and dynamic causal modelling was subsequently performed.
RESULTS
DBS improved the MDS-UPDRS-III score by 26.4% (DBS ON/Med ON vs. DBS OFF/Med ON). Active stimulation resulted in an increased effective connectivity from cerebellum to putamen (p = 0.00118). In addition, there was a stronger coupling from PFC to cerebellum (p = 0.021), as well as from cerebellum to SMA (p = 0.043) on an uncorrected level. Coupling strength from PFC to cerebellum correlated with the DBS-related change of the resting tremor subscore (r = 0.54, p = 0.031). Self-connections increased as a function of DBS in the right PFC, PMC, SMA, M1, thalamus and left cerebellum.
CONCLUSIONS
DBS-related improvement of Parkinsonian signs appears to be driven by an interaction between the cerebellum and the putamen. Resting tremor suppression may be related to an enhanced prefronto-cerebellar network. Activation of the mesial premotor loop (PFC-SMA) as seen in DRT may thus be secondary due to the primary modulation of cerebellar networks.

Identifiants

pubmed: 31494048
pii: S1353-8020(19)30378-5
doi: 10.1016/j.parkreldis.2019.09.003
pii:
doi:

Substances chimiques

Dopamine Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-104

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Henrike Hanssen (H)

Department of Neurology, University of Lübeck, Lübeck, Germany; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Julia Steinhardt (J)

Department of Neurology, University of Lübeck, Lübeck, Germany; Department of Internal Medicine, University of Lübeck, Lübeck, Germany.

Alexander Münchau (A)

Department of Internal Medicine, University of Lübeck, Lübeck, Germany.

Arkan Al-Zubaidi (A)

Department of Neurology, University of Lübeck, Lübeck, Germany.

Elinor Tzvi (E)

Department of Neurology, University of Leipzig, Leipzig, Germany.

Marcus Heldmann (M)

Department of Neurology, University of Lübeck, Lübeck, Germany; Institute of Psychology II, University of Lübeck, Lübeck, Germany.

Peter Schramm (P)

Institute of Neuroradiology, University of Lübeck, Lübeck, Germany.

Alexander Neumann (A)

Institute of Neuroradiology, University of Lübeck, Lübeck, Germany.

Dirk Rasche (D)

Department of Neurosurgery, University of Lübeck, Lübeck, Germany.

Assel Saryyeva (A)

Department of Neurosurgery, Medical School Hanover, MHH, Hanover, Germany.

Jürgen Voges (J)

Department of Stereotactic Neurosurgery, University Hospital Magdeburg, Magdeburg, Germany; Leibniz Institute of Neurobiology, Magdeburg, Germany.

Imke Galazky (I)

Department of Neurology, University Hospital Magdeburg, Magdeburg, Germany.

Lars Büntjen (L)

Department of Stereotactic Neurosurgery, University Hospital Magdeburg, Magdeburg, Germany.

Hans-Jochen Heinze (HJ)

Department of Neurology, University Hospital Magdeburg, Magdeburg, Germany.

Joachim K Krauss (JK)

Department of Neurosurgery, Medical School Hanover, MHH, Hanover, Germany.

Volker Tronnier (V)

Department of Neurosurgery, University of Lübeck, Lübeck, Germany.

Thomas F Münte (TF)

Department of Neurology, University of Lübeck, Lübeck, Germany; Institute of Psychology II, University of Lübeck, Lübeck, Germany.

Norbert Brüggemann (N)

Department of Neurology, University of Lübeck, Lübeck, Germany; Department of Internal Medicine, University of Lübeck, Lübeck, Germany. Electronic address: norbert.brueggemann@neuro.uni-luebeck.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH